Stay updated on Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new page revision (v3.6.2) was published, replacing the previous revision (v3.6.0) for the study details page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew sections for user guidance were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision note (Revision: v3.6.0) was included. The recruitment status was updated to 'No longer looking for participants', indicating there is no active enrollment at this time.SummaryDifference0.6%

- Check22 days agoChange DetectedThe page now reflects a new revision label (v3.5.5), replacing the previous v3.5.4. This indicates the content has been updated to a newer version.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small backend update to the page version.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Mifepristone in Advanced Breast Cancer Clinical Trial page.